SCHEMBL5865735

SCHEMBL5865735

Fc1cccc2c1C(F)(F)c1c(F)cccc1-2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.45
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
SRD5A1 P18405 1/20 0.35
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
ACHE P22303 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
BCHE P06276 1/20 0.31
NFE2L2 Q16236 3/20 0.31
AKR1A1 P14550 1/20 0.31
AKR1B1 P15121 1/20 0.31
NOTUM Q6P988 1/20 0.30
IDO1 P14902 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25564319 0.70 PDK2 (0.58) PDK2CA1CA2CA7CA9
SCHEMBL28180592 0.70 PDK2 (0.40) PDK2CA1CA2CA7CA9
SCHEMBL6284288 0.68 CA1 (0.33) PDK2CA1CA2CA7CA9
SCHEMBL20023635 0.67 PDK2 (0.55) PDK2ACHEAKR1A1AKR1B1ALDH1A1
SCHEMBL31538833 0.67 CA1 (0.44) PDK2CA1CA2CA7CA9
SCHEMBL22129686 0.67 CA1 (0.48) PDK2CA1CA2CA7CA9
SCHEMBL3038641 0.67 CES2 (0.46) CA1CA2CA7CA9CES2
SCHEMBL197834 0.65 ACHE (0.47) ACHEMAPTNFE2L2NOTUMIDO1
SCHEMBL29547174 0.65 ACHE (0.47) ACHEMAPTNFE2L2NOTUMIDO1
SCHEMBL5015496 0.65 CES2 (0.43) CA1CA2CA7CA9CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087272-B2 negative anisotropy of the dielectric constants; liquid-crystalline media and optical and electro-optical display elements MERCK PATENT GMBH (DE) 2006-08-08 US disclosed
US-20040106798-A1 negative anisotropy of the dielectric constants; liquid-crystalline media and optical and electro-optical display elements MERCK PATENT GMBH (DE) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106798-A1 negative anisotropy of the dielectric constants; liquid-crystalline media and optical and electro-optical display elements H1-0, F3, H1-2 PDK2 1158/4885CA1 672/4885CA2 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.